Skip to main content
VulnerabilityPublished

CVE-2026-105457: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in

Source GCVE Database

0
Authoritative record:CVE-2026-105457· Medium 6.5

Not known to be exploited · CVSS 6.5 Medium : upgrade to 2.3.5-1132 when convenient.

Data as of 28 Oct 2026, 14:30 UTC

CVSS 3.1 base score
6.5Medium
How severe the flaw is on the 0–10 CVSS scale.
Patch
Available – fixed in 2.3.5-1132
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 28 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Upgrade Liman MYS and havelsan/liman-mys to 2.3.5-1132.

Affected software

ProductAffectedFixed in
HAVELSAN Inc.Liman MYSAffected
  • <2.3.5-1132
Fixed in
  • 2.3.5-1132
Havelsanhavelsan/liman-myspkg:rpm/havelsan/liman-mysOther threatsAffected
  • <2.3.5-1132
Fixed in
  • 2.3.5-1132

Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.

AI-suggested

Since the affected versions are prior to 2.3.5-1132, upgrading to version 2.3.5-1132 or later is recommended if such a version includes a fix.

Description

CVE-2026-105457 is a path traversal vulnerability in HAVELSAN Inc. Liman MYS versions before 2.3.5-1132. This flaw allows an attacker with low privileges to access restricted directories by manipulating pathnames. The vulnerability has a CVSS 3.1 base score of 6.5, indicating a medium severity impact primarily affecting confidentiality without impacting integrity or availability.

References

Community reviews

Loading reviews…